Horizons Ventures

Horizons Ventures is an investment firm that backs companies working in deep science and technology, describing its focus as investing in fields such as synthetic biology and artificial intelligence. Its published material references a portfolio company, Carmot Therapeutics, which entered into a merger agreement with Roche, and highlights work in regenerative medicine within the human body. The firm frames its investment approach around identifying scientific and technological advances that it believes can have a wide impact, rather than focusing on a single industry. Beyond these examples, the site consists mainly of short statements about its outlook rather than detailed descriptions of individual investments or its typical deal size.